Lv4
610 积分 2024-01-24 加入
Efficacy and safety of monlunabant in adults with obesity and metabolic syndrome: a double-blind, randomised, placebo-controlled, phase 2a trial
4个月前
已完结
Impact of CB1 receptor antagonism on skeletal muscle hypertrophy and metabolic health: a systematic review of preclinical studies
7个月前
已完结
Tinlarebant. Retinol-binding protein 4 (RBP4) inhibitor, Treatment of Stargardt disease, Treatment of dry age-related macular degeneration
8个月前
已关闭
Peripheral CB1 receptor blockade for treatment of obesity
8个月前
已关闭
Efficacy and safety of monlunabant in adults with obesity and metabolic syndrome: a double-blind, randomised, placebo-controlled, phase 2a trial
8个月前
已完结
皖公网安备34019202002308
